The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Requip-Modutab 4 mg Prolonged-Release Tablets

IMED Healthcare Ltd.PPA1463/163/002

Main Information

Trade NameRequip-Modutab 4 mg Prolonged-Release Tablets
Active SubstancesRopinirole
Dosage FormProlonged-release tablet
Licence HolderIMED Healthcare Ltd.
Licence NumberPPA1463/163/002

Group Information

ATC CodeN04BC04 ropinirole


License statusAuthorised
Licence Issued07/05/2021
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back